EP1751279A4 - Acides nucleiques et polypeptides impliques dans la production de cryptophycine - Google Patents

Acides nucleiques et polypeptides impliques dans la production de cryptophycine

Info

Publication number
EP1751279A4
EP1751279A4 EP05779689A EP05779689A EP1751279A4 EP 1751279 A4 EP1751279 A4 EP 1751279A4 EP 05779689 A EP05779689 A EP 05779689A EP 05779689 A EP05779689 A EP 05779689A EP 1751279 A4 EP1751279 A4 EP 1751279A4
Authority
EP
European Patent Office
Prior art keywords
cryptophycin
production
nucleic acids
polypeptides involved
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05779689A
Other languages
German (de)
English (en)
Other versions
EP1751279A2 (fr
Inventor
David H Sherman
Nathan Mcgarvey
Zachary Q Beck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota
Original Assignee
University of Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota filed Critical University of Minnesota
Publication of EP1751279A2 publication Critical patent/EP1751279A2/fr
Publication of EP1751279A4 publication Critical patent/EP1751279A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP05779689A 2004-05-05 2005-05-05 Acides nucleiques et polypeptides impliques dans la production de cryptophycine Withdrawn EP1751279A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56833404P 2004-05-05 2004-05-05
PCT/US2005/015649 WO2005116200A2 (fr) 2004-05-05 2005-05-05 Acides nucleiques et polypeptides impliques dans la production de cryptophycine

Publications (2)

Publication Number Publication Date
EP1751279A2 EP1751279A2 (fr) 2007-02-14
EP1751279A4 true EP1751279A4 (fr) 2008-03-19

Family

ID=35451465

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05779689A Withdrawn EP1751279A4 (fr) 2004-05-05 2005-05-05 Acides nucleiques et polypeptides impliques dans la production de cryptophycine

Country Status (3)

Country Link
US (2) US7229814B2 (fr)
EP (1) EP1751279A4 (fr)
WO (1) WO2005116200A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022549971A (ja) 2019-09-30 2022-11-29 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン クリプトフィシン抗がん剤の生体触媒合成

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007798A1 (fr) * 1995-08-30 1997-03-06 Eli Lilly And Company Composes pharmaceutiques
WO1998038164A1 (fr) * 1997-02-26 1998-09-03 Eli Lilly And Company Procede d'epoxydation selective pour la preparation de composes pharmaceutiques

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US4874748A (en) 1986-03-24 1989-10-17 Abbott Laboratories Cloning vectors for streptomyces and use thereof in macrolide antibiotic production
US5149639A (en) 1986-03-24 1992-09-22 Abbott Laboratories Biologically pure cultures of streptomyces and use thereof in macrolide antibiotic production
US5063155A (en) 1988-03-28 1991-11-05 Eli Lilly And Company Method for producing 2"'-o-demethyltylosin
US5098837A (en) 1988-06-07 1992-03-24 Eli Lilly And Company Macrolide biosynthetic genes for use in streptomyces and other organisms
US4845085A (en) 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
US4845086A (en) 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
WO1993013663A1 (fr) 1992-01-17 1993-07-22 Abbott Laboratories Procede permettant d'effectuer la biosynthese de polycetides specifiques
US5672491A (en) 1993-09-20 1997-09-30 The Leland Stanford Junior University Recombinant production of novel polyketides
WO1995008548A1 (fr) 1993-09-20 1995-03-30 The Leland Stanford Junior University Production de nouveaux polycetides par recombinaison
US5712146A (en) 1993-09-20 1998-01-27 The Leland Stanford Junior University Recombinant combinatorial genetic library for the production of novel polyketides
US5952298A (en) 1993-12-21 1999-09-14 The University Of Hawaii Cryptophycins
CA2179490A1 (fr) 1993-12-21 1995-06-29 Trimurtulu Golakoti Nouvelles cryptophycines
JP3633629B2 (ja) 1995-07-06 2005-03-30 ザ レランド スタンフォード ジュニア ユニバーシティ ポリケチドの無細胞合成
US6033883A (en) 1996-12-18 2000-03-07 Kosan Biosciences, Inc. Production of polyketides in bacteria and yeast
US6399789B1 (en) 1996-12-18 2002-06-04 Kosan Biosciences, Inc. Multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides
NZ500693A (en) 1997-04-30 2004-01-30 Kosan Biosciences Inc Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold
US6090601A (en) 1998-01-23 2000-07-18 Kosan Bioscience Sorangium polyketide synthase
IL142165A0 (en) 1998-10-02 2002-03-10 Kosan Biosciences Inc Polyketide synthase enzymes and recombinant dna constructs therefor
EP1144375A2 (fr) 1999-01-27 2001-10-17 Kosan Biosciences Synthese de polycetides
US6524841B1 (en) 1999-10-08 2003-02-25 Kosan Biosciences, Inc. Recombinant megalomicin biosynthetic genes and uses thereof
US6589968B2 (en) 2001-02-13 2003-07-08 Kosan Biosciences, Inc. Epothilone compounds and methods for making and using the same
US6747021B2 (en) 2000-10-02 2004-06-08 Eli Lilly And Company Cryptophycin compound
WO2003082909A1 (fr) 2002-03-29 2003-10-09 Wyeth Peptide synthetases non ribosomales et genes biosynthetiques associes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007798A1 (fr) * 1995-08-30 1997-03-06 Eli Lilly And Company Composes pharmaceutiques
WO1998038164A1 (fr) * 1997-02-26 1998-09-03 Eli Lilly And Company Procede d'epoxydation selective pour la preparation de composes pharmaceutiques

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
AL-AWAR RIMA S ET AL: "A convergent approach to Cryptophycin 52 analogues: Synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.", JOURNAL OF MEDICINAL CHEMISTRY, vol. 46, no. 14, 3 July 2003 (2003-07-03), pages 2985 - 3007, XP002467582, ISSN: 0022-2623 *
BARROW R A ET AL: "TOTAL SYNTHESIS OF CRYPTOPHYCINS. REVISION OF THE STRUCTURES OF CRYPTOPHYCINS A AND C", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, vol. 117, no. 9, 8 March 1995 (1995-03-08), pages 2479 - 2490, XP002066281, ISSN: 0002-7863 *
BECKER J E ET AL: "Cloning, sequencing, and biochemical characterization of the nostocyclopeptide biosynthetic gene cluster: molecular basis for imine macrocyclization", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER, AMSTERDAM, NL, vol. 325, 21 January 2004 (2004-01-21), pages 35 - 42, XP004482493, ISSN: 0378-1119 *
DITTMANN E ET AL: "Molecular biology of peptide and polyketide biosynthesis in cyanobacteria", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, SPRINGER VERLAG, BERLIN, DE, vol. 57, no. 4, 2 October 2001 (2001-10-02), pages 467 - 473, XP002372134, ISSN: 0175-7598 *
EGGEN MARIJEAN ET AL: "The cryptophycins: Their synthesis and anticancer activity", MEDICINAL RESEARCH REVIEWS, vol. 22, no. 2, March 2002 (2002-03-01), pages 85 - 101, XP002467581, ISSN: 0198-6325 *
HEVEL J M ET AL: "Unraveling cryptophycin biosynthesis", FASEB JOURNAL, vol. 13, no. 7, 23 April 1999 (1999-04-23), & ANNUAL MEETING OF THE AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY ON BIOCHEMISTRY AND MOLECULAR BIOL; SAN FRANCISCO, CALIFORNIA, USA; MAY 16-20, 1999, pages A1349, XP009095589, ISSN: 0892-6638 *
MAGARVEY NATHAN A ET AL: "Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from Nostoc cyanobionts", ACS CHEMICAL BIOLOGY, vol. 1, no. 12, 2006, pages 766 - 779, XP002467583, ISSN: 1554-8929(print) 1554-8937(ele *
SALAMONCZYK G ET AL: "TOTAL SYNTHESIS OF CRYPTOPHYCINS VIA A CHEMOENZYMATIC APPROACH", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, US, vol. 61, no. 20, 1 October 1996 (1996-10-01), pages 6893 - 6900, XP000674616, ISSN: 0022-3263 *
SHIH C ET AL: "CRYPTOPHYCINS: A NOVEL CLASS OF POTENT ANTIMITOTIC ANTITUMOR DEPSIPEPTIDES", CURRENT PHARMACEUTICAL DESIGN, BENTHAM SCIENCE PUBLISHERS, SCHIPHOL, NL, vol. 7, no. 13, September 2001 (2001-09-01), pages 1259 - 1276, XP001121367, ISSN: 1381-6128 *

Also Published As

Publication number Publication date
WO2005116200A3 (fr) 2007-01-11
US7229814B2 (en) 2007-06-12
US7662599B2 (en) 2010-02-16
US20060057698A1 (en) 2006-03-16
WO2005116200A2 (fr) 2005-12-08
EP1751279A2 (fr) 2007-02-14
US20080050796A1 (en) 2008-02-28

Similar Documents

Publication Publication Date Title
EP1765992A4 (fr) Polypeptides galnact2 tronques et acides nucleiques
EP2102355A4 (fr) Protéines et peptides à action prolongée et procédés de production et d'utilisation de ces derniers
EP1856291A4 (fr) Acides nucléiques et protéines, et leurs procédés de production et d'utilisation
EP1824796A4 (fr) Squelettes proteiques et leurs utilisations
EP2037737A4 (fr) Protéines, acides nucléiques encodant celles-ci et leurs procédés d'utilisation associés
IL176923A0 (en) Structured materials and methods
IL179589A0 (en) Injection port and method of making the same
EP1979289A4 (fr) Materiaux ceramiques et leurs procede de fabrication et d'utilisation
EP1816358A4 (fr) Forme de vis et partie de vis ayant celle-ci
EP1815004A4 (fr) Reactions enzymatiques en presence d'acides cetoniques
HK1144956A1 (en) Sdf-1 binding nucleic acids and the use thereof sdf-1
GB2416542B (en) Fuel product and process
EP2029799A4 (fr) Protéines thermostables et procédés pour les préparer et les utiliser
EP1942947A4 (fr) Polypeptides de fibronectine et methodes d'utilisation
HK1119070A1 (en) Use of trans-clomiphene in the manufacture of medicines
EP1904845A4 (fr) Résultats et application améliorés d'épreuves de comparaison d'expressions protéiniques
ZA200804095B (en) Nucleic acids and proteins associated with galactomannan synthesis in coffee
IL193699A0 (en) Proteins, nucleic acids and medicaments
GB2435182B (en) Improvements in and relating to the DNA consideration process
GB0423681D0 (en) Vaccine and nucleic acids
EP1731610A4 (fr) Proteines conferant une tolerance vis-a-vis du bore et genes de celles-ci
GB0428136D0 (en) Novel materials and methods for the production thereof
EP1813671A4 (fr) Protéine soluble et utilisation de celle-ci
GB0428134D0 (en) Novel materials and methods for the production thereof
GB0617816D0 (en) Nucleic acids and methods of protein expression

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

17P Request for examination filed

Effective date: 20061205

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR LV MK YU

RIC1 Information provided on ipc code assigned before grant

Ipc: C07H 21/04 20060101ALI20070208BHEP

Ipc: C12P 19/60 20060101ALI20070208BHEP

Ipc: C12N 9/10 20060101ALI20070208BHEP

Ipc: C12N 1/20 20060101AFI20070208BHEP

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20080220

17Q First examination report despatched

Effective date: 20080915

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20111103